Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EGFR is a transmembrane receptor tyrosine kinase that belongs to the ErbB family of receptors. It plays a central role in regulating cell growth, survival, proliferation, and differentiation. Dysregulation of EGFR, through overexpression or activating mutations, is implicated in various cancers, making it an important therapeutic target. Therapeutic strategies targeting EGFR include monoclonal antibodies and small molecule inhibitors.
Tyrosine kinase inhibition, receptor blockade
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal Growth Factor Receptor kinase (EGFR).